全球醫療保健 IT（MedTech）行業：競爭格局

本報告考察了全球醫療保健 IT（MedTech）市場，並提供了市場和技術背景、COVID-19 的影響、監管框架、專利趨勢、競爭格局、市場份額和主要參與者。我有一個簡介等。

內容

第一章介紹

第二章市場與技術背景

• 進化
• 醫療技術的未來
• 醫療保健物聯網市場
• 醫療保健中的區塊鏈
• 3D 打印
• 醫療保健領域的人工智能
• 兌換環境
• 美國
• 歐洲
• 日本
• 其他地區
• FDA 批准的支持 AI 和 ML 的醫療設備

第 3 章 COVID-19 的影響

• 概覽
• 取消/延遲擇期手術
• 供應鏈中斷
• 在中國的強大影響力
• 對醫療設備的影響：按產品分類
• 家庭病理學

第 4 章法律框架和指南

• 醫療器械監管框架
• 聯邦法規 (CFR)
• 上市前通知 510 (k) 清關
• 510 (k) 豁免設備
• PMA（上市前批准）
• 良好的製造合規性 (GMP) 合規性
• 商業登記
• 設備註冊/列表
• 顯示要求
• 醫療器械報告 (MDR)
• 本地代理要求
• 醫療器械使用費
• 歐盟（歐盟）
• 日本
• 醫療保健 IT 法規
• CCHIT（醫療信息技術認證委員會）
• 聯邦法律等

第五章專利審查

第 6 章創業生態系統

第 7 章競爭格局分析

• 關鍵策略：產品發布
• 戰略審查：按公司分類
• 市場份額分析
• IVD 行業市場份額
• 醫療保健 IT 市場份額

第 8 章公司簡介

• 3M
• ABBOTT LABORATORIES
• ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
• ATHENAHEALTH
• B. BRAUN MELSUNGEN AG
• BECTON, DICKINSON AND CO.
• BIOMERIEUX SA
• BIO-RAD LABORATORIES INC.
• BOSTON SCIENTIFIC CORP.
• CARDINAL HEALTH INC.
• CANON MEDICAL SYSTEM CORP.
• CERNER CORP.
• COCHLEAR AMERICAS
• COGNIZANT
• DANAHER
• EDWARD LIFESCIENCES CORP.
• EPIC SYSTEMS CORP.
• FUJIFILM HOLDING CORP.
• GE HEALTHCARE
• HITACHI LTD.
• HOLOGIC INC.
• INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
• INTEL CORP.
• JOHNSON & JOHNSON SERVICES INC.
• LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
• MCKESSON CORP.
• MEDTRONIC PLC
• MICROSOFT CORP.
• NANO-X IMAGING LTD.
• OLYMPUS CORP.
• PHILIPS HEALTHCARE
• ROCHE HOLDING AG
• SAMSUNG ELECTRONICS INC.
• SIEMENS HEALTHCARE
• SMITH & NEPHEW PLC
• STRYKER CORP.
• TERUMO CORP.
• UNITEDHEALTH GROUP
• ZOLL MEDICAL CORP.

Highlights:

This report includes extensive competitive landscapes, patent analyses, startup ecosystem evaluation, recent developments, innovations and other factors that provide insights into the MedTech market. It also includes Major players, competitive intelligence, innovative technologies and company profiles, which are discussed in detail.

Report Scope:

This report incorporates an in-depth analysis of the MedTech market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail. The report also examines major players' recent developments and product portfolios, along with market share analysis and ranking in the market. Regulatory landscape analysis focuses on recent regulations in the U.S., Europe and Japan. The MedTech industry scope includes the medical device industry, IVD diagnostics and the Healthcare IT industry (AI, digital health, blockchain, etc.).

Report Includes:

• 29 data tables and 77 additional tables
• An updated assessment of the global MedTech market and industry competitive landscape
• Discussion of current and future demand in the global MedTech industry, along with a detailed analysis of the competitive environment, market regulations, and reimbursement practices
• Review of patents granted on medical technology by each major category, and emerging developments in the global MedTech market
• Identification of the companies best positioned to meet the increasing demand for medical device industry, IVD diagnostics, and the Healthcare IT industry owing to their proprietary technologies, M&A deals, new developments and other growth strategies
• In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, and COVID-19 implications on the progress of this market
• Market share analysis of the key market participants in the MedTech industry, along with their research priorities, product portfolios, global rankings, and company competitive landscape
• Company profiles of major players, including Cardinal Health Inc., McKesson, Microsoft, General Electric Co. (GE), Johnson & Johnson Services Inc., Hitachi Medical Corp.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Methodology
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Market and Technology Background

• Evolution
• Future of Medical Technology
• Healthcare IoT Market
• Blockchain in Healthcare
• 3D Printing
• Artificial Intelligence in Healthcare
• Reimbursement Practices
• United States
• Europe
• Japan
• RoW
• FDA-Approved AI and ML-Enabled Medical Devices

Chapter 3 Impact of COVID-19

• Overview
• Decline/Delay in Elective Procedures
• Supply Chain Disruptions
• Strong Impact in China
• Impact of COVID 19 on Medical Device Product Segments
• Home-Based Pathology

Chapter 4 Regulatory Framework and Guidelines

• Regulatory Framework for Medical Devices
• Code of Federal Regulations (CFR)
• Premarket Notification 510(k) Clearance to Market
• 510 (k) Exempt Devices
• PMA (Pre-Market Approval)
• Good Manufacturing Compliance (GMP) Compliance
• Establishment Registration
• Device Registration and Listing
• Labelling Requirement
• Medical Device Reporting (MDR)
• Local Agent Requirements
• Medical Device User Fee
• European Union (EU)
• Japan
• Regulations for Healthcare IT
• Certification Commission for Healthcare Information Technology
• Federal Legislation
• Better Healthcare Through Information Technology Act of 2005
• Medicare Value Purchasing Act
• Health Information Technology Promotion Act
• Wired for Healthcare Quality Act
• American Recovery and Reinvestment Act of 2009
• Patient Protection and Affordable Care Act of 2010
• Continuing Extension Act of 2010
• Electronic Health Records Improvement Act of 2012
• Food and Drug Administration Safety and Innovation Act
• Healthcare IT Regulatory Schemes in China
• Regulatory Scenario of Healthcare IT in Singapore
• EU Approach to Regulation
• Regulatory Framework for Telemedicine
• American Diabetes Association's Standards of Medical Care in Diabetes
• ATA Guidelines for Artificial Intelligence (AI)
• Indian AI Guidelines, Strategy and Standards

Chapter 5 Patent Review

• Introduction
• Patent Review by Company
• IBM
• Other Major Players
• Patent Review by Geography

Chapter 6 Start-up Ecosystem

• Introduction

Chapter 7 Competitive Landscape Analysis

• Primary Strategies: Product Launch
• Strategic Review by Company
• Market Share Analysis
• Market Share of IVD Industry
• Market Share of Healthcare IT

Chapter 8 Company Profiles

• 3M
• ABBOTT LABORATORIES
• ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
• ATHENAHEALTH
• B. BRAUN MELSUNGEN AG
• BECTON, DICKINSON AND CO.
• BIOMERIEUX SA
• BIO-RAD LABORATORIES INC.
• BOSTON SCIENTIFIC CORP.
• CARDINAL HEALTH INC.
• CANON MEDICAL SYSTEM CORP.
• CERNER CORP.
• COCHLEAR AMERICAS
• COGNIZANT
• DANAHER
• EDWARD LIFESCIENCES CORP.
• EPIC SYSTEMS CORP.
• FUJIFILM HOLDING CORP.
• GE HEALTHCARE
• HITACHI LTD.
• HOLOGIC INC.
• INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
• INTEL CORP.
• JOHNSON & JOHNSON SERVICES INC.
• LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
• MCKESSON CORP.
• MEDTRONIC PLC
• MICROSOFT CORP.
• NANO-X IMAGING LTD.
• OLYMPUS CORP.
• PHILIPS HEALTHCARE
• ROCHE HOLDING AG
• SAMSUNG ELECTRONICS INC.
• SIEMENS HEALTHCARE
• SMITH & NEPHEW PLC
• STRYKER CORP.
• TERUMO CORP.
• UNITEDHEALTH GROUP
• ZOLL MEDICAL CORP.

List of Tables

• Table 1 : FDA-Cleared AI Medical Products, Radiology and Other Imaging Modalities, U.S., 2018-2021
• Table 2 : Class I and Class II Devices Exempted from Premarket Approval
• Table 3 : Medical Device User Fee Amendments (MDUFA): 2020
• Table 4 : Regulatory Approval: U.S. Versus Europe
• Table 5 : Global Regulatory Framework, Telemedicine, by Country
• Table 6 : Patents Granted to IBM, 2022-Present
• Table 7 : Other Patents Granted to Major Market Players, 2022
• Table 8 : Start-ups, Global MedTech Market, 2015-2021
• Table 9 : Major Market Strategies, Global MedTech Market, 2019-2022
• Table 10 : Products Launched, Medical Technology, by Key Market Player, 2019-2022
• Table 11 : 3M: Products and Services
• Table 12 : 3M: Company Financials, 2019
• Table 13 : 3M: Recent Developments, 2015-2020
• Table 14 : Abbott: Product Portfolio
• Table 15 : Abbott: Recent Developments, 2021 and 2022
• Table 16 : Allscripts Healthcare Solutions Inc.: Products
• Table 17 : Allscripts Healthcare Solutions Inc.: Financials, 2018-2020
• Table 18 : Allscripts Healthcare Solutions Inc.: Recent Developments, 2020-2022
• Table 19 : Athenahealth: Product Portfolio
• Table 20 : Athenahealth: Recent Developments, 2021 and 2022
• Table 21 : B. Braun Melsungen AG: Product Description
• Table 22 : B. Braun Melsungen AG: Company Financials, 2018
• Table 23 : Becton, Dickinson and Co.: Company Financials, 2019
• Table 24 : Beckton, Dickinson and Co.: Product Portfolio
• Table 25 : Beckton, Dickinson and Co.: Recent Developments, 2020-2022
• Table 26 : bioMerieux: Products and Services
• Table 27 : bioMerieux: Recent Developments, 2018-2020
• Table 28 : Bio-Rad Laboratories: Company Financials, 2019
• Table 29 : Bio-Rad Laboratories: Products and Services
• Table 30 : Bio-Rad Laboratories: Recent Developments, 2018-2020
• Table 31 : Boston Scientific Corp.: Recent Developments, 2020 and 2021
• Table 32 : Cardinal Health: Product Portfolio
• Table 33 : Cardinal Health: Company Financials, 2019
• Table 34 : Cardinal Health: Recent Developments, 2013-2019
• Table 35 : Canon Medical System: Company Financials, 2019-2021
• Table 36 : Canon Medical System: Product Portfolio
• Table 37 : Canon Medical System: Strategies and Developments, 2020 and 2021
• Table 38 : Cerner Corp.: Product Portfolio
• Table 39 : Cerner Corp.: Financial Performance, 2018-2020
• Table 40 : Cerner Corp.: Strategies and Developments, 2019-2022
• Table 41 : Cognizant: Healthcare Technology Solutions
• Table 42 : Cognizant: Financial Performance, 2018-2020
• Table 43 : Danaher: Product Portfolio
• Table 44 : Danaher: Company Financials, 2019
• Table 45 : Danaher: Products and Services
• Table 46 : Danaher: Recent Developments, 2015-2020
• Table 47 : Edward LifeSciences Corp.: Company Financials, 2019
• Table 48 : Edwards Lifesciences Corp.: Revenue, by Product Segment, 2018 and 2019
• Table 49 : Edward LifeSciences Corp.: Recent Developments, 2017-2019
• Table 50 : Epic Systems Corp.: Solutions
• Table 51 : Fujifilm Holding: Company Financials, 2020 and 2021
• Table 52 : Fujifilm Holding Corp.: Product Portfolio
• Table 53 : Product Portfolio
• Table 54 : Fujifilm Holding Corp.: Strategies and Developments, 2019 and 2020
• Table 55 : GE: Financial Performance, 2019 and 2020
• Table 56 : GE Healthcare: Product Portfolio
• Table 57 : GE Healthcare: Strategies and Developments, 2019-2022
• Table 58 : Hitachi Medical Corp.: Products and Services
• Table 59 : Hitachi Medical Corp.: Company Financials, 2019
• Table 60 : Hitachi Medical Corp.: Key Developments and Strategies, 2016-2020
• Table 61 : Hologic Inc.: Company Financials, 2019
• Table 62 : Hologic Inc.: Developments and Strategies, 2017-2020
• Table 63 : IBM Corp.: Company Financials, 2019 and 2020
• Table 64 : IBM Corp.: Product Portfolio
• Table 65 : IBM Corp.: Strategies and Developments, 2018-2021
• Table 66 : Intel Corp.: Product Portfolio
• Table 67 : Intel Corp.: Company Financials, 2019 and 2020
• Table 68 : Johnson & Johnson: Company Financials, 2019
• Table 69 : Johnson & Johnson: Product Description
• Table 70 : Johnson & Johnson: Recent Developments and Strategies, 2017 and 2018
• Table 71 : McKesson Corp.: Business Segment
• Table 72 : McKesson Corp.: Financial Performance, 2017-2020
• Table 73 : Medtronic plc: Product Portfolio
• Table 74 : Medtronic plc: Patient Monitoring Device Product Portfolio
• Table 75 : Medtronic plc: Strategies and Developments, 2019-2021
• Table 76 : Microsoft Corp.: Company Financials, 2019 and 2020
• Table 77 : Microsoft Corp.: Product Portfolio
• Table 78 : Microsoft Corp.: Strategies and Developments, 2019-2021
• Table 79 : Nano-X AI: Product Portfolio
• Table 80 : Nano-X AI: Strategies and Developments, 2020 and 2021
• Table 81 : Nano-X AI: MSaaS Agreements, 2020
• Table 82 : Olympus Corp.: Product Portfolio
• Table 83 : Olympus Corp.: Company Financials, 2019
• Table 84 : Olympus Corp.: Recent Developments, 2016-2020
• Table 85 : Phillips Healthcare: Company Financials, 2019 and 2020
• Table 86 : Philips Healthcare: Product Portfolio, AI in Diagnostics
• Table 87 : Phillips Healthcare: Strategies and Developments, 2020 and 2021
• Table 88 : F. Hoffmann-La Roche Ltd.: Company Financials, 2019 and 2020
• Table 89 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2019 and 2020
• Table 90 : F. Hoffmann-La Roche Ltd.: Product Portfolio
• Table 91 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2020-2022
• Table 92 : Samsung Electronics Inc.: Product Portfolio
• Table 93 : Samsung Electronics Inc.: Strategic Developments, 2021
• Table 94 : Siemens Healthcare GmbH: Product Segments
• Table 95 : Siemens Healthcare GmbH: Products
• Table 96 : Siemens Healthcare GmbH: Company Financials, 2020 and 2021
• Table 97 : Siemens Healthcare GmbH: Key Developments
• Table 98 : Smith & Nephew plc: Company Financials, 2019
• Table 99 : Smith & Nephew plc: Product Portfolio
• Table 100 : Smith & Nephew plc: Recent Developments, 2015-2017
• Table 101 : Stryker Corp.: Product Description
• Table 102 : Terumo Corp.: Company Financials, 2019
• Table 103 : Terumo Corp.: Recent Developments, 2020
• Table 104 : UnitedHealth Group: Businesses
• Table 105 : UnitedHealth Group: Financial Performance, 2018-2020
• Table 106 : Zoll Medical Corp.: Product Portfolio

List of Figures

• Figure 1 : FDA-Approved AI Medical Products, Radiology and Other Imaging, U.S., by Modality, 2018-2021
• Figure 2 : Share of FDA-Approved AI Algorithms, Diagnostics, U.S., by Company, 2018-2021
• Figure 3 : Patents Granted to IBM, 2021 and 2022
• Figure 4 : Patents Granted to Other Major Players, 2019-2021
• Figure 5 : Share of Patents Granted in MedTech, by Country, 2021-2022
• Figure 6 : Start-ups, MedTech Industries, by Country, 2000 and 2021
• Figure 7 : Key Strategies, by Market Players During, 2019-2022
• Figure 8 : Key Strategies, by Company, 2018-2021
• Figure 9 : Number of Strategic Actions, by Company, 2018-2021
• Figure 10 : Global Market Share Analysis, IVD Industry, by Key Companies, 2021
• Figure 11 : Global Market Share Analysis, Healthcare IT, by Key Company 2021
• Figure 12 : 3M: Revenue, by Business Segment, 2019
• Figure 13 : 3M: Revenue, by Region, 2019
• Figure 14 : Abbott: Annual Revenue, 2018-2021
• Figure 15 : Abbott: Vascular Business Annual Revenue, 2018-2021
• Figure 16 : Abbott: Revenue, by Country, 2021
• Figure 17 : Allscripts Healthcare Solutions Inc.: Revenue, by Business Segment, 2020
• Figure 18 : Allscripts Healthcare Solutions Inc.: Revenue, by Region, 2020
• Figure 19 : Boston Scientific Corp.: Annual Revenue, 2018-2021
• Figure 20 : Boston Scientific Corp.: Revenue, by Business Segment, 2021
• Figure 21 : Boston Scientific Corp.: Revenue, by Region, 2021
• Figure 22 : Cerner Corp.: Revenue, by Business Model, 2020
• Figure 23 : Cerner Corp.: Revenue, by Region, 2020
• Figure 24 : Cognizant: Revenue, by Business Segment, 2020
• Figure 25 : Cognizant: Revenue, by Region, 2020
• Figure 26 : Danaher: Revenue, by Segment, 2019
• Figure 27 : Danaher: Revenue, by Region, 2019
• Figure 28 : Edwards LifeSciences Corp.: Revenue, by Segment, 2019
• Figure 29 : Edwards LifeSciences Corp.: Revenue, by Region, 2019
• Figure 30 : GE: Revenue, by Business Segment, 2020
• Figure 31 : GE Healthcare: Revenue, by Region, 2020
• Figure 32 : Hitachi Medical Corp.: Revenue, by Region, 2019
• Figure 33 : Hitachi Medical Corp.: Revenue, by Business Segment, 2019
• Figure 34 : Hitachi Medical Corp.: Revenue, by Smart Life Sub-Segment, 2019
• Figure 35 : Hologic Inc. Annual Revenue, 2014-2019
• Figure 36 : Hologic Inc.: Revenue, by Region, 2019
• Figure 37 : Hologic Inc.: Revenue, by Segment, 2019
• Figure 38 : IBM Corp.: Revenue, by Business Segment, 2020
• Figure 39 : Intel Corp.: Revenue, by Region, 2020
• Figure 40 : Johnson & Johnson: Annual Revenue, 2017-2019
• Figure 41 : Johnson & Johnson: Revenue, by Region, 2019
• Figure 42 : Johnson & Johnson: Revenue, by Segment, 2019
• Figure 43 : McKesson Corp.: Revenue, by Business Segment, 2020
• Figure 44 : McKesson Corp.: Revenue, by Region, 2020
• Figure 45 : Medtronic plc: Annual Revenue, 2018-2021
• Figure 46 : Medtronic plc: Coronary and Peripheral Vascular Segment, Annual Revenue, 2019-2021
• Figure 47 : Medtronic plc: Revenue, by Region, 2021
• Figure 48 : Microsoft Corp.: Revenue, by Region, 2020
• Figure 49 : Olympus Corp.: Revenue, by Business Segment, 2019
• Figure 50 : Olympus Corp.: Revenue, by Region, 2019
• Figure 51 : Phillips Healthcare: Revenue, by Region, 2020
• Figure 52 : F. Hoffmann-La Roche Ltd.: Revenue, by Business Segment, 2019
• Figure 53 : F. Hoffmann-La Roche Ltd.: Revenue, by Region/Country, 2019
• Figure 54 : Siemens Healthcare GmbH: Revenue, by Business Segment, 2020
• Figure 55 : Siemens Healthcare GmbH: Revenue, by Region, 2019
• Figure 56 : Smith & Nephew plc: Revenue, by Business Segment, 2019
• Figure 57 : Smith & Nephew: Revenue, by Region, 2019
• Figure 58 : Terumo Corp.: Revenue, by Segment, 2018
• Figure 59 : Terumo Corp.: Revenue, by Region, 2018
• Figure 60 : UnitedHealth Group: Revenue, by Business Segment, 2020